Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study.
Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study.
D. Ben-Shachar,O. Bonne,5 Authors,N. Freedman
2007 · DOI: 10.1016/J.PNPBP.2006.12.025
Progress in Neuro-psychopharmacology and Biological Psychiatry · 69 Citations
TLDR
The results suggest that the correlation between peripheral complex I activity and rCGM in regions implicated in schizophrenia, could be a pathological factor that is differentially expressed in subgroups of schizophrenic patients.